These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17084874)

  • 1. Strain differences in the responsiveness between Sprague-Dawley and Fischer rats to nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor.
    Ashizawa N; Shimo T; Matsumoto K; Oba K; Nakazawa T; Nagata O
    Toxicol Appl Pharmacol; 2006 Dec; 217(3):260-5. PubMed ID: 17084874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on species differences in nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor.
    Shimo T; Ashizawa N; Moto M; Iwanaga T; Nagata O
    Arch Toxicol; 2011 May; 85(5):505-12. PubMed ID: 20936465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FYX-051, a xanthine oxidoreductase inhibitor, induces nephropathy in rats, but not in monkeys.
    Shimo T; Ashizawa N; Moto M; Matsumoto K; Iwanaga T; Nagata O
    Toxicol Pathol; 2009 Jun; 37(4):438-45. PubMed ID: 19336671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous treatment with citrate prevents nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor, in rats.
    Shimo T; Ashizawa N; Matsumoto K; Nakazawa T; Nagata O
    Toxicol Sci; 2005 Sep; 87(1):267-76. PubMed ID: 15933230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on toxicological aspects of crystal-mediated nephrotoxicity induced by FYX-051, a xanthine oxidoreductase inhibitor, in rats.
    Shimo T; Moto M; Ashizawa N; Oba K; Nagata O
    Drug Chem Toxicol; 2011 Apr; 34(2):192-8. PubMed ID: 21314469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of simultaneous treatment model with citrate for preventing nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor, in rats.
    Ashizawa N; Shimo T; Matsumoto K; Taniguchi T; Moto M; Nagata O
    Drug Chem Toxicol; 2011 Apr; 34(2):151-61. PubMed ID: 21105859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profile of FYX-051 (4-(5-pyridin-4-yl-1h-[1,2,4]triazol-3-yl)pyridine-2-carbonitrile) in the rat, dog, monkey, and human: identification of N-glucuronides and N-glucosides.
    Nakazawa T; Miyata K; Omura K; Iwanaga T; Nagata O
    Drug Metab Dispos; 2006 Nov; 34(11):1880-6. PubMed ID: 16914512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthine crystals induced by topiroxostat, a xanthine oxidoreductase inhibitor, in rats, cause transitional cell tumors.
    Shimo T; Moto M; Ashizawa N; Matsumoto K; Iwanaga T; Saito K
    Arch Toxicol; 2014 Apr; 88(4):1035-42. PubMed ID: 24448833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity.
    Corley RA; Wilson DM; Hard GC; Stebbins KE; Bartels MJ; Soelberg JJ; Dryzga MD; Gingell R; McMartin KE; Snellings WM
    Toxicol Appl Pharmacol; 2008 Apr; 228(2):165-78. PubMed ID: 18191429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of light cycle phase on morphine-induced conditioned taste aversions in the Lewis, Fischer and Sprague-Dawley rat strains.
    Gomez-Serrano MA; Kearns DN; Riley AL
    Behav Brain Res; 2009 Jan; 196(1):116-22. PubMed ID: 18706935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
    Horiuchi H; Ota M; Kobayashi M; Kaneko H; Kasahara Y; Nishimura S; Kondo S; Komoriya K
    Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ weights and fat volume in rats as a function of strain and age.
    Schoeffner DJ; Warren DA; Muralidara S; Bruckner JV; Simmons JE
    J Toxicol Environ Health A; 1999 Apr; 56(7):449-62. PubMed ID: 10201633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FYX-051: a novel and potent hybrid-type inhibitor of xanthine oxidoreductase.
    Matsumoto K; Okamoto K; Ashizawa N; Nishino T
    J Pharmacol Exp Ther; 2011 Jan; 336(1):95-103. PubMed ID: 20952484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxicity induced by N-(3,5-dichlorophenyl)-3-hydroxysuccinamic acid in male and female Fischer 344 rats.
    Rankin GO; Hong SK; Anestis DK
    J Appl Toxicol; 2008 Oct; 28(7):867-73. PubMed ID: 18418842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine-induced renal structural damage: influence of dosage, strain, age and sex with reference to the rat and guinea pig.
    Duncan JI; Thomson AW; Aldridge RD; Simpson JG; Whiting PH
    Clin Nephrol; 1986; 25 Suppl 1():S14-7. PubMed ID: 3708924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats.
    Sudo T; Ito H; Hayashi H; Nagamura Y; Toga K; Yamada Y
    Thromb Haemost; 2007 Apr; 97(4):665-72. PubMed ID: 17393031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics/pharmacodynamics of Y-700, a novel xanthine oxidase inhibitor, in rats and man.
    Yamada I; Fukunari A; Osajima T; Kamezawa M; Mori H; Iwane J
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1123-5. PubMed ID: 15571214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of hexachlorobutadiene to alpha 2u-globulin and its role in nephrotoxicity in rats.
    Pähler A; Birner G; Ott MM; Dekant W
    Toxicol Appl Pharmacol; 1997 Dec; 147(2):372-80. PubMed ID: 9439732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat.
    Williams RE; Lock EA
    Toxicology; 2005 Feb; 207(1):35-48. PubMed ID: 15590120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.